BASF’s Renewed Pursuit of Evonik Signals Strategic Accumulation
BASF SE has announced a fresh attempt to acquire German specialty‑chemical group Evonik AG, with a potential offer that could reach €28 per share. The announcement, released early on Friday, follows a series of incremental concessions made by BASF to the company’s stakeholders in order to secure the political and shareholder approval required for a merger of this magnitude. The latest bid is expected to be submitted within the next few business days.
Market Reactions and Investor Sentiment
Evonik’s stock has rallied sharply in response to the takeover speculation. On Wednesday, the shares spiked to €22.50, the highest level since June 2022, up 1.9 %. By Friday, the share price had settled near €21.40, reflecting a modest 1 % gain amid broader market softness. The volatility underscores investors’ sensitivity to the valuation terms and the likelihood of regulatory clearance, particularly from the North Rhine‑Westphalia ministry which has voiced strong opposition to the merger.
Financial analysts remain cautious. While the premium proposed by BASF is significantly higher than the last offer, the company’s current price‑earnings ratio of 22.18 and the €45 billion market cap suggest that any substantial upside would require a clear demonstration of long‑term synergies. Moreover, the German competition authority’s scrutiny of the merger’s impact on the chemicals sector adds an additional layer of uncertainty.
Strategic Rationale Behind the Bid
BASF’s pursuit of Evonik is rooted in a broader strategy to consolidate its position in the specialty‑chemicals arena. By integrating Evonik’s portfolio of performance products, functional solutions and agricultural chemicals, BASF would gain immediate access to new markets and advanced technologies that complement its existing six‑segment structure. The anticipated synergies include cross‑sales opportunities, cost efficiencies in procurement and R&D, and a strengthened footprint in the German and European markets.
The company’s decision to raise the offer to €28 per share signals an aggressive stance aimed at outbidding any competing offers and assuaging concerns from Evonik’s shareholders and regulators. It also reflects BASF’s confidence in its financial strength, as evidenced by its robust capital base and continued investment in decarbonisation initiatives, such as the recent report from BASF Agricultural Solutions on scaling agricultural decarbonisation.
Forward‑Looking Outlook
If BASF succeeds in securing the necessary approvals, the acquisition would represent one of the largest consolidation moves in the European chemicals sector in recent years. The transaction is expected to unlock value for both companies’ shareholders, provided that post‑merger integration is managed effectively and that the combined entity can navigate the evolving regulatory landscape.
Market participants will be closely watching the next few days for the formal presentation of the offer and the subsequent responses from Evonik’s board and key stakeholder groups. In the meantime, the strategic narrative remains clear: BASF is positioning itself to solidify its leadership in a rapidly converging industry, while Evonik’s shareholders weigh the merits of a higher premium against the broader strategic benefits that such a merger could deliver.




